Pfizer will only deliver half the vaccines it expected to this year


Pfizer Inc. will only be able to deliver half the COVID-19 vaccine doses it promised to ship by the end of the year, the company said Thursday.
Pfizer and its German partner BioNTech SE projected it would distribute 100 million vaccines worldwide in 2020, but has cut that to 50 million. "Scaling up the raw material supply chain took longer than expected," a spokesperson told The Wall Street Journal, and the vaccine's clinical trial finished "somewhat later than the initial projection" as well. A person directly involved in the vaccine's development meanwhile said "some early batch of raw material failed to meet the standards," leading Pfizer to miss this year's projections.
The U.K. on Wednesday granted an emergency-use authorization for Pfizer's two-shot vaccine, making it the first Western country to do so. The U.S. Food and Drug Administration is reviewing Pfizer's vaccine for a similar authorization after it proved safe and effective at stopping the transmission of COVID-19.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
September 7 editorial cartoons
Cartoons Sunday’s political cartoons include stressing about Powerball, and a busy FBI schedule
-
Nvidia: unstoppable force, or powering down?
Talking Point Sales of firm's AI-powering chips have surged above market expectations –but China is the elephant in the room
-
5 hard-working cartoons about Labor Day celebrations
Cartoons Artists take on creation of AI, spelling mistakes, and more
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC